Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, ...

Dave Coulier shared an update about his cancer treatment on the latest episode of his "Full House Rewind" podcast.

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...

NEW YORK (PIX11) — A young man, homeless and disheveled, was surrounded by a joint response team made up of two NYPD officers ...

Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for ...

Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label Study ...

Asengeprast is under clinical development by Certa Therapeutics and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

Ianalumab is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma).

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Different medical conditions, aging, and lifestyle habits can all contribute to these symptoms. When nondrug strategies fail to help, medications are available to address symptoms and improve quality ...

Image: Adobe Stock “There’s a lot of interest in the use of medications like the glucagon-like peptide 1, or GLP-1, receptor agonists, because these medications have multiple different ...

LOS ANGELES—Noah Hudnut’s family had already spent $150,000 on his psychiatric care when he was hauled in handcuffs by police to the emergency room of UCLA medical center. On top of the ...